Symbol="ABCL"
AssetType="Common Stock"
Name="Abcellera BiologicsÂ Inc"
Description="AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada."
CIK="1703057"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2215 YUKON STREET, VANCOUVER, BC, CA"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1607373000"
EBITDA="-86232000"
PERatio="None"
PEGRatio="None"
BookValue="4.132"
DividendPerShare="0"
DividendYield="0"
EPS="-0.26"
RevenuePerShareTTM="0.506"
ProfitMargin="-0.509"
OperatingMarginTTM="-0.743"
ReturnOnAssetsTTM="-0.0431"
ReturnOnEquityTTM="-0.0614"
RevenueTTM="145175000"
GrossProfitTTM="311109000"
DilutedEPSTTM="-0.26"
QuarterlyEarningsGrowthYOY="0.459"
QuarterlyRevenueGrowthYOY="-0.781"
AnalystTargetPrice="25.38"
TrailingPE="-"
ForwardPE="27.47"
PriceToSalesRatioTTM="4.933"
PriceToBookRatio="2.318"
EVToRevenue="3.491"
EVToEBITDA="5.61"
Beta="-0.0706"
num_52WeekHigh="14.97"
num_52WeekLow="5.37"
num_50DayMovingAverage="6.67"
num_200DayMovingAverage="8.4"
SharesOutstanding="289356000"
DividendDate="None"
ExDividendDate="None"
symbol="ABCL"
open="5.66"
high="5.84"
low="5.59"
price="5.80"
volume="1752114.00"
latest_trading_day="2023-08-30"
previous_close="5.66"
change="0.14"
change_percent="2.4735%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="67"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="2638481"
Change_recent_avg="-0.02"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="-0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="135"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0041.jpeg"
image_negative_thumbnail_id_2="1131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="667"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0041.jpeg"
image_positive_thumbnail_id_2="973"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
